AHK peptide and microneedling for hair loss: what the science says

What did @david_padilla86 actually say?

Honestly, this video is more question than claim. David is asking his audience whether AHK peptide is worth trying for hair regrowth, specifically framing it as "an actual attempt at hair regrowth" compared to GHK-Cu, which he suggests mainly makes existing hair "come in fuller." He also mentions considering an at-home microneedling pen alongside it. He is not stating that AHK works, he is crowdsourcing experience.

That framing matters. He is not making a therapeutic claim, he is asking for anecdotes. But the implicit premise, that AHK is a legitimate next step up from GHK-Cu for someone with hair loss, is worth examining on its own merits. The distinction he draws between GHK-Cu causing fuller hair versus AHK enabling actual regrowth is a specific idea that deserves scrutiny.

Does the science back this up?

The evidence for AHK in hair regrowth is real but thin. Do not let anyone oversell it. A 2018 study by Sohn and colleagues published in the Journal of Dermatological Science found that AHK-Cu, the copper-chelated form of the tripeptide, promoted hair follicle proliferation in vitro and showed some activity comparable to minoxidil in mouse models. That is meaningful early data, not a clinical green light.

The distinction David implies between GHK-Cu and AHK is loosely grounded in peptide biology. GHK-Cu has broader tissue repair and anti-inflammatory activity, while AHK-Cu appears to have more follicle-specific signaling effects. However, no published randomized controlled trials in humans compare these two peptides head-to-head for androgenetic alopecia. The claim that AHK is categorically better for actual regrowth is ahead of the available evidence.

• Sohn et al. (2018, Journal of Dermatological Science): AHK-Cu stimulated hair follicle cell proliferation in vitro
• Mouse model data showed results comparable to minoxidil, but animal-to-human translation is unreliable
• No peer-reviewed human clinical trials on AHK for hair loss exist as of 2024

What did they get wrong (or right)?

Credit where it is due: David is not claiming AHK is a proven treatment. He is asking a genuine question and acknowledging uncertainty, saying he is "not sure if that will help or save me at this point." That kind of epistemic humility is rare in peptide content and it is worth acknowledging.

Where he introduces an unsupported idea is in the implicit framing that AHK represents a meaningful upgrade over GHK-Cu for regrowth specifically. The scientific literature does not clearly support that hierarchy. GHK-Cu has its own published evidence for hair-related effects, including a 2019 paper by Pickart and Margolina in Biomedicines describing its role in hair follicle signaling. Neither peptide has strong enough human data to rank one clearly above the other for regrowth purposes.

The at-home microneedling angle also deserves a flag. Microneedling has legitimate evidence behind it for hair loss when performed correctly. A 2013 RCT by Dhurat et al. in the International Journal of Trichology showed microneedling combined with minoxidil outperformed minoxidil alone. But at-home devices vary widely in needle depth, sterility, and technique, and combining them with topical peptides raises contamination and absorption risks that are not well studied in consumer settings.

What should you actually know?

If you are considering peptides for hair loss, here is the honest picture. AHK-Cu shows interesting preclinical activity but has not been validated in human trials. GHK-Cu has a longer research history but similarly lacks large-scale clinical RCTs for hair loss specifically. Neither peptide has FDA approval for this use, and both are typically available only through compounding pharmacies, which introduces its own quality control considerations.

Microneedling is a different category. It has actual randomized trial support for alopecia, though the evidence is strongest when performed in a clinical setting with standardized devices. Combining an unvalidated peptide with an at-home device on your scalp is a stack that has essentially zero safety or efficacy data behind it as a combined protocol.

If hair loss is a genuine concern, the treatments with the strongest evidence base remain FDA-approved options. Anyone exploring peptide-based approaches should do so through a licensed provider who can assess suitability, monitor response, and source compounds from compliant pharmacies. Crowdsourcing peptide protocols on TikTok is not a substitute for that.